Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 236.50m |
Free float | 234.08m |
P/E (TTM) | 23.57 |
Market cap | 2.46bn USD |
EPS (TTM) | 0.4406 USD |
--
More ▼
Announcements
- De første børn er vaccineret i nyt klinisk forsøg, der sigter mod at udvide indikationen for Bavarian Nordics mpox-vaccine
- First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine
- Bavarian Nordic indgår aftale med UNICEF om levering af 1 million doser mpox-vaccine
- Bavarian Nordic opjusterer sine økonomiske forventninger til 2024
- Bavarian Nordic Upgrades its Financial Guidance for 2024
- Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
- Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
- Bavarian Nordic modtager USD 63 mio. fra den amerikanske regering for produktion og levering af yderligere koppe- og mpoxvacciner
- Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
- Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
More ▼